Hospital Universitario Gaffree e Guinle

Rio de Janeiro RJ 20270-004

0 studies enrolling now · 4 studies all time

What they study most

Multiple Sclerosis, Multiple Sclerosis, Primary Progressive, Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD)

Studies at this site

• A Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Satralizumab in Participants With Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease — Running, not enrolling
• A Rollover Study to Evaluate the Long-Term Safety and Efficacy of Ocrelizumab In Patients With Multiple Sclerosis — Running, not enrolling
• A Study to Evaluate the Efficacy and Safety of Fenebrutinib Compared With Ocrelizumab in Adult Participants With Primary Progressive Multiple Sclerosis — Running, not enrolling
• Efficacy and Safety of Fingolimod in Patients With Relapsing-remitting Multiple Sclerosis With Optional Extension Phase — Completed